Pharmacist
Outline the guideline directed medical therapy for patients with co-morbid diabetes and cardiovascular disease
Compare and contrast evidence-based treatment options that optimize glycemic control and reduce cardiovascular events in patients with co-morbid type 2 diabetes and cardiovascular disease and in those with heart failure alone.
Describe a patient with heart failure who would benefit from the addition of a SGLT2 inhibitor to their medication therapy.
Identify appropriate strategies to communicate the evidence-based treatment approaches for patients with comorbid diabetes and heart failure to both patients and members of the healthcare team.
Pharmacy Technician
Outline the guideline directed medical therapy for patients with co-morbid diabetes and cardiovascular disease
Compare and contrast evidence-based treatment options that optimize glycemic control and reduce cardiovascular events in patients with co-morbid type 2 diabetes and cardiovascular disease and in those with heart failure alone.
Describe a patient with heart failure who would benefit from the addition of a SGLT2 inhibitor to their medication therapy.
Identify appropriate strategies to communicate the evidence-based treatment approaches for patients with comorbid diabetes and heart failure to both patients and members of the healthcare team.
Nurse
Outline the guideline directed medical therapy for patients with co-morbid diabetes and cardiovascular disease
Compare and contrast evidence-based treatment options that optimize glycemic control and reduce cardiovascular events in patients with co-morbid type 2 diabetes and cardiovascular disease and in those with heart failure alone.
Describe a patient with heart failure who would benefit from the addition of a SGLT2 inhibitor to their medication therapy.
Identify appropriate strategies to communicate the evidence-based treatment approaches for patients with comorbid diabetes and heart failure to both patients and members of the healthcare team.